Dr. Reddy's Laboratories Limited (DRREDDY) — share transfer

· NSE Neutral
📢 Key Event
Confirmation certificate issued for dematerialised securities under SEBI Regulation 74(5).
💡 Investor Takeaway
The filing confirms routine compliance with share dematerialisation and transfer regulations, with no material changes or future implications.

Dr. Reddy's Laboratories disclosed a SEBI-mandated confirmation certificate from its share transfer agent, Bigshare Services Private Limited, covering dematerialised securities for the quarter ended June 30, 2026. The certificate verifies that securities received from depositories were accepted by depositories and that certificates were cancelled after verification. It also confirms that registered owners were updated within 15 days of dematerialisation.

📄 View Original Announcement (PDF)

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DRREDDY — Free

Free account · 2 AI queries/day